Literature DB >> 7654125

Meta-analyses of studies of ventricular enlargement and cortical sulcal prominence in mood disorders. Comparisons with controls or patients with schizophrenia.

H Elkis1, L Friedman, A Wise, H Y Meltzer.   

Abstract

BACKGROUND: The findings of ventricular enlargement and increased sulcal prominence are well documented in schizophrenia, but the consistency of similar findings in mood disorders is less well appreciated. Reliable documentation of the presence of these structural abnormalities in mood disorders would require a reassessment of their significance for both schizophrenia and mood disorders. In this article, we meta-analytically review the literature on ventricular enlargement and cortical sulcal prominence in patients with mood disorders compared with controls and patients with schizophrenia.
METHODS: Four meta-analytic reviews were conducted, two comparing patients with mood disorders with normal controls on ventricular enlargement (meta-analysis 1) or sulcal prominence (meta-analysis 2) and two comparing patients with mood disorders with schizophrenic patients on these same measures (meta-analyses 3 and 4).
RESULTS: Meta-analyses 1 and 2 revealed statistically significant (P < .001) moderate composite effect sizes (d) for the comparisons of patients with mood disorders with controls on both ventricular enlargement (d = 0.44) and sulcal prominence (d = 0.42). Meta-analysis 3 further revealed that patients with schizophrenia have significantly greater ventricular enlargement than patients with mood disorders (P = .002), but the effect size was small (d = -0.20). There were too few studies comparing these patient groups on sulcal prominence to support a quantitative meta-analysis.
CONCLUSIONS: This review documents the presence of ventricular enlargement and increased sulcal prominence in mood disorders. Patients with mood disorders have less ventricular enlargement than patients with schizophrenia, but this effect is small. These results reinforce previous suggestions of the nonspecificity of structural brain changes in schizophrenia and mood disorders.

Entities:  

Mesh:

Year:  1995        PMID: 7654125     DOI: 10.1001/archpsyc.1995.03950210029008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  27 in total

Review 1.  MRI anatomy of schizophrenia.

Authors:  R W McCarley; C G Wible; M Frumin; Y Hirayasu; J J Levitt; I A Fischer; M E Shenton
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

Review 2.  Diagnosing schizophrenia circa 2005: how and why?

Authors:  Laurie M McCormick; Michael Flaum
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

Review 3.  Volumetric brain imaging studies in the elderly with mood disorders.

Authors:  John L Beyer
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

4.  Inferring pathobiology from structural MRI in schizophrenia and bipolar disorder: Modeling head motion and neuroanatomical specificity.

Authors:  Nailin Yao; Anderson M Winkler; Jennifer Barrett; Gregory A Book; Tamara Beetham; Rachel Horseman; Olivia Leach; Karen Hodgson; Emma E Knowles; Samuel Mathias; Michael C Stevens; Michal Assaf; Theo G M van Erp; Godfrey D Pearlson; David C Glahn
Journal:  Hum Brain Mapp       Date:  2017-05-08       Impact factor: 5.038

5.  The early course of schizophrenia and depression*.

Authors:  Heinz Häfner; Kurt Maurer; Günter Trendler; Wolfram an der Heiden; Martin Schmidt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

6.  Volume deficits of subcortical nuclei in mood disorders A postmortem study.

Authors:  Hendrik Bielau; Kurt Trübner; Dieter Krell; Marcus W Agelink; Hans-Gert Bernstein; Renate Stauch; Christian Mawrin; Peter Danos; Lieselotte Gerhard; Bernhard Bogerts; Bruno Baumann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-08-17       Impact factor: 5.270

Review 7.  The common genetic liability between schizophrenia and bipolar disorder: a review.

Authors:  E Bramon; P C Sham
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

8.  The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

Authors:  Maria Neves-Pereira; Emanuela Mundo; Pierandrea Muglia; Nicole King; Fabio Macciardi; James L Kennedy
Journal:  Am J Hum Genet       Date:  2002-08-02       Impact factor: 11.025

Review 9.  Comparison of prefrontal cell pathology between depression and alcohol dependence.

Authors:  José J Miguel-Hidalgo; Grazyna Rajkowska
Journal:  J Psychiatr Res       Date:  2003 Sep-Oct       Impact factor: 4.791

10.  Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.

Authors:  Alessio Squassina; Mirko Manchia; Maria Del Zompo
Journal:  Hum Genomics Proteomics       Date:  2010-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.